# AlphaImpactRx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alphaimpactrx

- Industry: Pharmaceuticals
- Headquarters: Mount Laurel, US
- Website: www.impactrx.com
- Total disclosed funding: $27M
- Latest round: Series D (Sep 15, 2004)
- Investors on record: 4

## About

Founded in 2000 and based in US, ImpactRx operates as a promotion research organization for the pharmaceutical industry. Through the add-on acquisitions of TargetRx and AlphaDetail, the entity is now known as AlphaImpactRx.

## Funding rounds

- Series D, Sep 15, 2004, $14M — 3i, Mediphase Venture Partners, Oxford Bioscience Partners, Merck Capital Ventures
- Series C, Jul 8, 2003, $3M — Merck Capital Ventures
- Series C, May 9, 2002, $10M — Mediphase Venture Partners, Oxford Bioscience Partners

## Investors

- Mediphase Venture Partners (https://capitalatlas.ai/funds/mediphase-venture-partners) — Series C, Series D
- Oxford Bioscience Partners (https://capitalatlas.ai/funds/oxford-bioscience-partners) — Series C, Series D
- Merck Capital Ventures (https://capitalatlas.ai/funds/merck-capital-ventures) — Series C, Series D
- 3i (https://capitalatlas.ai/funds/3i) — Series D